Superpharm Bolton Ltd - Period Ending 2019-07-31
Superpharm Bolton Ltd - Period Ending 2019-07-31
Registration number:
Superpharm Bolton Ltd
for the Year Ended 31 July 2019
1 Pavilion Square
Cricketers Way
Westhoughton
Bolton
BL5 3AJ
Superpharm Bolton Ltd
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Financial Statements |
Superpharm Bolton Ltd
Company Information
|
Directors |
Mr K Iqbal Mr I Khan Mr KUH Hussain Mr SS Khan Mr M Naheem |
|
Registered office |
|
|
Accountants |
|
|
Page 1 |
Superpharm Bolton Ltd
(Registration number: 09449153)
Balance Sheet as at 31 July 2019
|
Note |
2019 |
(As Restated) |
|
|
Fixed assets |
|||
|
Other financial assets |
1,814,134 |
1,814,134 |
|
|
Current assets |
|||
|
Debtors |
|
|
|
|
Cash at bank and in hand |
|
|
|
|
|
|
||
|
Creditors: Amounts falling due within one year |
( |
( |
|
|
Net current liabilities |
( |
( |
|
|
Total assets less current liabilities |
|
|
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
|
|
Net assets |
|
|
|
|
Capital and reserves |
|||
|
Called up share capital |
|
|
|
|
Share premium reserve |
|
|
|
|
Profit and loss account |
|
|
|
|
Total equity |
|
|
For the financial year ending 31 July 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.
|
Page 2 |
Superpharm Bolton Ltd
(Registration number: 09449153)
Balance Sheet as at 31 July 2019
Approved and authorised by the
.........................................
Director
.........................................
Director
|
Page 3 |
Superpharm Bolton Ltd
Notes to the Financial Statements for the Year Ended 31 July 2019
|
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
These financial statements were authorised for issue by the
|
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Going concern
The financial statements have been prepared on a going concern basis.
Prior period errors
An error was identified in the opening balance sheet at 01 August 2018 in relation to the value of investments in subsidiaries, debtors and creditors due within 1 year in the financial statements. The original investment value of £2,359,905 was reduced by £545,771 to £1,814,134 with a corresponding reduction in creditors from £759,692 to £251,571 and an increase in debtors of £37,650. There was no effect on opening net assets at 01 August 2018 or on the reported profit for the year ended 31 July 2018.
Tax
The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
|
Page 4 |
Superpharm Bolton Ltd
Notes to the Financial Statements for the Year Ended 31 July 2019
Borrowings
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.
|
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
|
Other financial assets (current and non-current) |
|
Financial assets at cost less impairment |
Total |
|
|
Non-current financial assets |
||
|
Cost or valuation |
||
|
At 1 August 2018 (As Restated) |
1,814,134 |
1,814,134 |
|
At 31 July 2019 |
1,814,134 |
1,814,134 |
|
Impairment |
||
|
Carrying amount |
||
|
At 31 July 2019 |
|
1,814,134 |
|
Page 5 |
Superpharm Bolton Ltd
Notes to the Financial Statements for the Year Ended 31 July 2019
|
Debtors |
|
Note |
2019 |
(As Restated) |
|
|
Amounts owed by group undertakings and undertakings in which the company has a participating interest |
|
|
|
|
Other debtors |
|
|
|
|
|
|
|
Creditors |
Creditors: amounts falling due within one year
|
Note |
2019 |
(As Restated) |
|
|
Due within one year |
|||
|
Bank loans and overdrafts |
|
|
|
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
|
|
|
|
Accruals and deferred income |
|
|
|
|
Other creditors |
|
|
|
|
|
|
Creditors: amounts falling due after more than one year
|
Note |
2019 |
2018 |
|
|
Due after one year |
|||
|
Loans and borrowings |
|
|
|
Page 6 |
Superpharm Bolton Ltd
Notes to the Financial Statements for the Year Ended 31 July 2019
|
Loans and borrowings |
|
2019 |
2018 |
|
|
Non-current loans and borrowings |
||
|
Bank borrowings |
|
|
|
2019 |
2018 |
|
|
Current loans and borrowings |
||
|
Bank borrowings |
|
|
|
Page 7 |